Status:
RECRUITING
Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients
Lead Sponsor:
Soonchunhyang University Hospital
Collaborating Sponsors:
Ministry of Health & Welfare, Korea
Conditions:
Age Problem
Dialysis; Complications
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
As Korea is becoming a super-aged society, the number of elderly patients with end-stage kidney disease (ESKD) is expected to increase rapidly. Therefore, the burden on Korean society will also increa...
Detailed Description
End-stage kidney disease (ESKD) poses a substantial public health challenge, with the number of patients requiring renal replacement therapy (RRT) globally reaching 2.61 million in 2010 and projected ...
Eligibility Criteria
Inclusion
- Age ≥60 years
- Clinical diagnosis of end stage kidney disease
- Starting maintenance hemodialysis within one month
- 24-hour urine output ≥ 500 ml at randomization
- Sufficient understanding of the study procedures and requirements.
Exclusion
- Left ventricular ejection fraction \< 40%)
- Liver cirrhosis
- Current treatment for an active malignancy or active infection
- Onability or refusal to provide written informed consent
- enrollment in another clinical trial.
Key Trial Info
Start Date :
November 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
428 Patients enrolled
Trial Details
Trial ID
NCT06141798
Start Date
November 23 2021
End Date
May 31 2026
Last Update
May 31 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Soonchunhyang University Hospital Bucheon
Bucheon-si, South Korea
2
Hallym University Medical Center- Chuncheon
Chuncheon, South Korea
3
Soonchunhyang University Seoul Hospital
Seoul, South Korea, 04401
4
Kangbuk Samsung Medical Center
Seoul, South Korea